As more and more people are getting their COVID-19 vaccinations, one of the companies responsible for their creation is still looking for ways to improve them. David Meline, a former CFO at Amgen and the current CFO at Moderna, was one of five biotech leaders to speak at BioMedley, an online event featuring prominent biotech…
This article is only available to Business Times subscribers
Subscribers: LOG IN or REGISTER for complete digital access.
Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
